<DOC>
	<DOCNO>NCT00092170</DOCNO>
	<brief_summary>The purpose study determine effect approve medication adult investigational use pediatric patient 3 month 17 year treatment complicate intra-abdominal infection acute pelvic infection .</brief_summary>
	<brief_title>An Investigational Agent Treatment Complicated Intra-Abdominal Infections Acute Pelvic Infections ( 0826-038 )</brief_title>
	<detailed_description>The duration treatment 18 month .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Intraabdominal Infections</mesh_term>
	<mesh_term>Pelvic Infection</mesh_term>
	<mesh_term>Pelvic Inflammatory Disease</mesh_term>
	<mesh_term>Clavulanic Acid</mesh_term>
	<mesh_term>Clavulanic Acids</mesh_term>
	<mesh_term>Ertapenem</mesh_term>
	<mesh_term>Ticarcillin</mesh_term>
	<criteria>Patients age 3 month 17 year intraabdominal infection acute pelvic infection Immune problem Kidney problem</criteria>
	<gender>All</gender>
	<minimum_age>3 Months</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Intra-abdominal infection</keyword>
	<keyword>Acute pelvic infection</keyword>
</DOC>